National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS)

The National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) was established in 1996. NARMS is a collaboration among state and local public health departments, CDC, the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture (USDA).

This national public health surveillance system tracks changes in the antimicrobial susceptibility of certain enteric (intestinal) bacteria found in ill people (CDC), retail meats (FDA), and food animals (USDA) in the United States. The NARMS program at CDC helps protect public health by providing information about emerging bacterial resistance, the ways in which resistance is spread, and how resistant infections differ from susceptible infections.

Spotlight
COVID-19 U.S. Impact on Antimicrobial Resistance report cover

COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022

 

NARMS 2019 Integrated Report Summary cover

2019 NARMS Integrated Report Summary

 

Antibiotic Resistance Investments online tool to learn more about CDC activities to combat antibiotic resistance

CDC’s antibiotic resistance investment map provides state-by-state information on funding to combat antibiotic resistance in multiple areas, including food safety.